Sobering read, some good, some bad, some ugly ... and lots of reality.

I wonder if Don still believes (allegedly) that RVX is worth $3-4b to somebody now, today? ... post-TLD, given the other positives and knowns?

He has acted like he could make a deal if needed, "money is not an issue" ... "lots of interest in RVX" ...

I would think FDA disposition and applications & filings are key? And potentially warrants exercise for cash flow to get through application processes, and further negotiations & due diligence?

If things were to potentially get dire, I would think $1b is better than "ceasing operations" ... hard to believe some BP out there wouldn't spend at least $1b to avoid bidding and competing at a Sheriff's Auction for apabetalone and a leadership position in epigenetics for Cardio, Renal, VD, among some other areas?

The next 90-120 days seem pretty important to valuation, as well as Sep2020 (debenture).

Seems clear something significant MUST happen soon. At some price, or arrangement. A lot of "potential" market value, and IP on the line. And probably (likely?) shark-ish discussions built around opportunity vs desperation ... greed and fear

Hopefully, this science gets to market to help sick people. With an ROI for the investors.

jmho's